CN117414319A - Nanometer eye cream of Aronia melanocarpa extract fermented by lactobacillus plantarum and preparation method thereof - Google Patents
Nanometer eye cream of Aronia melanocarpa extract fermented by lactobacillus plantarum and preparation method thereof Download PDFInfo
- Publication number
- CN117414319A CN117414319A CN202311389706.7A CN202311389706A CN117414319A CN 117414319 A CN117414319 A CN 117414319A CN 202311389706 A CN202311389706 A CN 202311389706A CN 117414319 A CN117414319 A CN 117414319A
- Authority
- CN
- China
- Prior art keywords
- aronia melanocarpa
- extract
- preparation
- lactobacillus plantarum
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000005662 Aronia melanocarpa Species 0.000 title claims abstract description 127
- 235000007425 Aronia melanocarpa Nutrition 0.000 title claims abstract description 127
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 61
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 61
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 61
- 239000006071 cream Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims description 49
- 239000002502 liposome Substances 0.000 claims abstract description 51
- 239000004480 active ingredient Substances 0.000 claims abstract description 20
- 229940119217 chamomile extract Drugs 0.000 claims abstract description 19
- 235000020221 chamomile extract Nutrition 0.000 claims abstract description 19
- 238000000855 fermentation Methods 0.000 claims abstract description 18
- 230000004151 fermentation Effects 0.000 claims abstract description 18
- 238000009629 microbiological culture Methods 0.000 claims abstract description 8
- 238000004321 preservation Methods 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 103
- 239000000706 filtrate Substances 0.000 claims description 57
- 229920001282 polysaccharide Polymers 0.000 claims description 50
- 239000005017 polysaccharide Substances 0.000 claims description 50
- 150000004676 glycans Chemical class 0.000 claims description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 47
- 235000020248 camel milk Nutrition 0.000 claims description 46
- 239000000203 mixture Substances 0.000 claims description 36
- 238000004108 freeze drying Methods 0.000 claims description 35
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 35
- 239000012498 ultrapure water Substances 0.000 claims description 35
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 32
- 238000002156 mixing Methods 0.000 claims description 32
- 238000001914 filtration Methods 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 30
- 239000000341 volatile oil Substances 0.000 claims description 30
- 238000001816 cooling Methods 0.000 claims description 29
- 235000013399 edible fruits Nutrition 0.000 claims description 29
- 238000003756 stirring Methods 0.000 claims description 29
- 238000001035 drying Methods 0.000 claims description 27
- 229940089161 ginsenoside Drugs 0.000 claims description 25
- 229930182494 ginsenoside Natural products 0.000 claims description 25
- 238000010438 heat treatment Methods 0.000 claims description 21
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- 229920001184 polypeptide Polymers 0.000 claims description 20
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 20
- 239000012528 membrane Substances 0.000 claims description 19
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 16
- 229930003268 Vitamin C Natural products 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 235000019154 vitamin C Nutrition 0.000 claims description 16
- 239000011718 vitamin C Substances 0.000 claims description 16
- 238000005303 weighing Methods 0.000 claims description 16
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 15
- 240000003553 Leptospermum scoparium Species 0.000 claims description 15
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 15
- 238000007710 freezing Methods 0.000 claims description 15
- 230000008014 freezing Effects 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 238000010992 reflux Methods 0.000 claims description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 12
- 240000007472 Leucaena leucocephala Species 0.000 claims description 12
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 12
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 11
- 229920002674 hyaluronan Polymers 0.000 claims description 11
- 229960003160 hyaluronic acid Drugs 0.000 claims description 11
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 10
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 10
- 244000068988 Glycine max Species 0.000 claims description 10
- 235000010469 Glycine max Nutrition 0.000 claims description 10
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 239000011159 matrix material Substances 0.000 claims description 10
- 239000000661 sodium alginate Substances 0.000 claims description 10
- 235000010413 sodium alginate Nutrition 0.000 claims description 10
- 229940005550 sodium alginate Drugs 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 244000223014 Syzygium aromaticum Species 0.000 claims description 9
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 8
- 239000012074 organic phase Substances 0.000 claims description 8
- 238000009210 therapy by ultrasound Methods 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 7
- 238000000502 dialysis Methods 0.000 claims description 7
- 239000012071 phase Substances 0.000 claims description 7
- 230000001376 precipitating effect Effects 0.000 claims description 7
- 244000144730 Amygdalus persica Species 0.000 claims description 5
- 241000723418 Carya Species 0.000 claims description 5
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 5
- 244000042664 Matricaria chamomilla Species 0.000 claims description 5
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 240000004713 Pisum sativum Species 0.000 claims description 5
- 235000010582 Pisum sativum Nutrition 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 238000003916 acid precipitation Methods 0.000 claims description 5
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 5
- 239000006185 dispersion Substances 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 5
- 239000003517 fume Substances 0.000 claims description 5
- 235000008434 ginseng Nutrition 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 239000008223 sterile water Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000002137 ultrasound extraction Methods 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 230000002195 synergetic effect Effects 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims 5
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 239000002537 cosmetic Substances 0.000 abstract description 6
- 241000186660 Lactobacillus Species 0.000 abstract description 5
- 229940039696 lactobacillus Drugs 0.000 abstract description 5
- 239000013543 active substance Substances 0.000 abstract description 3
- 238000013461 design Methods 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 32
- 235000019441 ethanol Nutrition 0.000 description 30
- 241001122767 Theaceae Species 0.000 description 20
- 239000000126 substance Substances 0.000 description 14
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 239000000499 gel Substances 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 235000013824 polyphenols Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 8
- 229930002877 anthocyanin Natural products 0.000 description 8
- 235000010208 anthocyanin Nutrition 0.000 description 8
- 239000004410 anthocyanin Substances 0.000 description 8
- 150000004636 anthocyanins Chemical class 0.000 description 8
- 150000002772 monosaccharides Chemical class 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 5
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 5
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 5
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000001212 derivatisation Methods 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 238000001819 mass spectrum Methods 0.000 description 5
- -1 nitrile acetate derivative Chemical class 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 240000004371 Panax ginseng Species 0.000 description 4
- 241001092391 Sorbus Species 0.000 description 4
- 235000014459 Sorbus Nutrition 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000002211 ultraviolet spectrum Methods 0.000 description 4
- 239000012224 working solution Substances 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 229940097043 glucuronic acid Drugs 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 241000872931 Myoporum sandwicense Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000005536 corrosion prevention Methods 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 238000004807 desolvation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 239000008057 potassium phosphate buffer Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 150000003214 pyranose derivatives Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- RHCSKNNOAZULRK-APZFVMQVSA-N 2,2-dideuterio-2-(3,4,5-trimethoxyphenyl)ethanamine Chemical compound NCC([2H])([2H])C1=CC(OC)=C(OC)C(OC)=C1 RHCSKNNOAZULRK-APZFVMQVSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 206010024612 Lipoma Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002831 nitrogen free-radicals Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 229930182487 phenolic glycoside Natural products 0.000 description 1
- 150000007950 phenolic glycosides Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 150000003244 quercetin derivatives Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010563 solid-state fermentation Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/986—Milk; Derivatives thereof, e.g. butter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the technical field of cosmetics, and discloses a nano eye cream of a Aronia melanocarpa extract after fermentation of lactobacillus plantarum, wherein the lactobacillus plantarum is lactobacillus plantarum OPB15, and the name of the lactobacillus plantarum is: OPB15, class name: lactobacillus plantarum (Lactobacillus), accession number: CGMCC No.27735, date of preservation: 2023, 6, 29, deposit unit: china general microbiological culture Collection center, north Chen Xi Lu No. 1, 3, the Korean region of Beijing, and the China general microbiological culture Collection center. The invention applies the active ingredients of the Aronia melanocarpa after fermentation to the design of skin care products such as eye cream and the like, mixes and encapsulates the active substances of the Aronia melanocarpa and the chamomile extract together by using a liposome technology, optimizes and screens the technological parameters of the liposome nanotechnology, and exerts the skin care effect to the greatest extent.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a nano eye cream of a Aronia melanocarpa extract after lactobacillus plantarum fermentation and a preparation method thereof.
Background
The eye cream is a skin care cosmetic product for periocular skin, has the effects of improving skin moisturizing and barrier functions, and sometimes has the effects of tightening eye skin, relieving dark circles, improving wrinkles and fine lines according to the addition of functional components and active substances of different products.
The eye skin of a person is weak and is more vulnerable to external environment, and is one of the most susceptible parts to aging. The aging is characterized by a series of phenomena such as skin thickness reduction, moisture content reduction, skin relaxation, fine wrinkles increase, black eye circles, skin pigmentation around eyes, darkness and the like on the skin of eyes, and the reasons are that the antioxidant capacity of the skin is reduced, lipofuscin accumulation, collagen synthesis capacity is reduced, hyaluronic acid content is reduced, skin moisture content is reduced and the like.
Aronia melanocarpa (academic name: aronia melanocarpa (Michx.) Elliott) has antioxidant, antitumor, antiinflammatory, antibacterial, etc. physiological activities, and flavone, anthocyanin, and polyphenol in fruit are the highest in known plants, and exceed those of blueberry, etc., and have high polysaccharide content. The Aronia melanocarpa extract has special effect in treating cancer, diabetes, cardiovascular and cerebrovascular diseases, and can improve immunity, regulate blood sugar and blood lipid, improve liver function, and prevent and treat cardiovascular diseases.
The prior eye cream with functions of repairing eye skin, resisting wrinkles, resisting oxidization and the like has no obvious common effect, takes effect after long-time use on the functions of tightening, resisting wrinkles, repairing and the like, is sensitive and fragile to the eye skin, and is easy to cause skin allergy and skin discomfort due to a large amount of chemical substance raw materials contained in the eye cream.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a Aronia melanocarpa extract nanometer eye cream fermented by lactobacillus plantarum and a preparation method thereof.
The technical scheme adopted for solving the technical problems is as follows:
the lactobacillus plantarum is lactobacillus plantarum OPB15, and the name of the lactobacillus plantarum is that of the lactobacillus plantarum is Aronia melanocarpa extract nanometer eye cream after lactobacillus plantarum fermentation: OPB15, class name: lactobacillus plantarum (Lactobacillus plantarum), accession number: CGMCC No.27735, date of preservation: 2023, 6, 29, deposit unit: china general microbiological culture Collection center, north Chen Xi Lu No. 1, 3, the Korean region of Beijing, and the China general microbiological culture Collection center.
The preparation method of the Aronia melanocarpa extract nanometer eye cream comprises the following steps of:
(1) Mixing active polypeptide, ginsenoside, flos Matricariae Chamomillae extract, aronia melanocarpa polysaccharide, and fermented Aronia melanocarpa extract with camel milk liposome under stirring, incubating at 35+ -1deg.C for 10+ -1 min, and continuously stirring; spin-drying water to form a honeycomb membrane, adding puer tea extract, dissolving the honeycomb membrane, and performing ultrasonic treatment for 10 minutes under the pressure of 2500psi to obtain camel milk liposome encapsulating active ingredients; heating camel milk liposome encapsulated with active ingredients to 70+/-1 ℃;
wherein the active polypeptide: ginsenoside: chamomile extract: aronia melanocarpa polysaccharide: and (3) fermenting the Aronia melanocarpa extract: camel milk liposome: the mass ratio of the puer tea extract is 1:1:1:2:3:8:1, a step of;
(2) Adding acacia and sodium alginate into water, stirring to obtain gel matrix, adding active ingredient-entrapped camel milk liposome into the gel matrix at 70+ -1deg.C, stirring to uniformity, and adding vitamin C and vitamin E; continuously stirring until the mixture is uniform, and preserving the temperature for 10+/-1 minutes to obtain a mixture;
wherein, acacia: sodium alginate: camel milk liposome encapsulating active ingredients: vitamin C: the mass ratio of the vitamin E is 1:1:4:1:1, a step of;
(3) Cooling the mixture to 30-45 ℃, adding ultrapure water into hyaluronic acid, trehalose, tea tree essential oil and clove essential oil, mixing, stirring uniformly, adding into the mixture prepared in the step (2), shaking uniformly, standing until no precipitate exists, adding ultrapure water and acacia gum, and regulating the viscosity of eye cream, thus obtaining the fermented black chokeberry extract nanometer eye cream;
wherein, hyaluronic acid: trehalose: tea tree essential oil: butyl essential oil: ultrapure water added for the first time: the mass ratio of the mixture prepared in the step (2) is 0.8:1:1:1:5:10.
further, the preparation method of the puer tea extract in the step (1) comprises the following steps:
weighing puer tea, crushing, and drying until the quality is unchanged, wherein the liquid-to-material ratio is 1:30 adding ultrapure water, heating and refluxing at 80 ℃ for 1.5 hours, cooling, vacuum filtering to obtain filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, freeze-drying in a freeze dryer, and freeze-drying into powder after 12 hours to obtain the puer tea extract.
Further, the preparation method of the chamomile extract in the step (1) comprises the following steps:
weighing stems and leaves of chamomile, drying until the mass is no longer changed, crushing into powder, and mixing according to a liquid-to-material ratio of 1:15 adding ultrapure water, heating and refluxing for 3 hours at 85 ℃, cooling, vacuum filtering to obtain a filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, freeze-drying in a freeze dryer, and freeze-drying into powder after 12 hours to obtain the chamomile extract.
Further, the preparation method of the ginsenoside in the step (1) comprises the following steps:
weighing ginseng, crushing, and drying until the quality is unchanged, wherein the liquid-to-material ratio is 1:10 adding ultrapure water, heating and refluxing at 77 ℃ for 3 hours, cooling, vacuum filtering to obtain filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, and then freeze-drying in a freeze dryer for 12 hours to obtain ginsenoside dry powder, thus obtaining the ginsenoside extract.
Further, the preparation method of the Aronia melanocarpa polysaccharide in the step (1) comprises the following steps:
1) Taking Aronia melanocarpa, placing in a filter paper bucket, folding the opening of the filter paper bucket, sealing, placing in a Soxhlet extractor, extracting with diethyl ether at 54 deg.C until the diethyl ether is clear, taking out the filter paper wrapped with black fruit, and placing in a fume hood to volatilize the residual diethyl ether;
2) Extracting black fruit with water at 77 deg.C for 90 min, precipitating with ethanol to obtain filtrate, extracting the residue once again, mixing the filtrates, and filtering to obtain clear liquid; concentrating, namely concentrating the Aronia melanocarpa to 10ml per 15g, and precipitating the Aronia melanocarpa with 92% ethanol overnight; centrifuging at 7000rpm for 10 min, removing supernatant, washing precipitate with diethyl ether and ethanol for 2 times, and dissolving with hot water after volatilizing solvent;
3) After the addition of sevage reagent (chloroform: the volume ratio of n-butanol is 4: 1) Deproteinizing, shaking for 30min, standing for separating protein, removing organic phase and protein between water phase and organic phase for 5-6 times; dialyzing with dialysis bag (MD 44-10000) for 12 hr, and lyophilizing to obtain Aronia melanocarpa polysaccharide.
Further, the preparation method of the Aronia melanocarpa extract after fermentation in the step (1) comprises the following steps:
taking Aronia melanocarpa fruits and soybeans, crushing, drying until the fruits are unchanged, sterilizing, adding sterile water to be sticky, adding lactobacillus plantarum OPB15 bacteria powder, shaking uniformly, culturing in a constant-temperature incubator for 48 hours, taking out, soaking with 5-10 times of ethanol, performing ultrasonic extraction, centrifuging, filtering to obtain filtrate, cooling to room temperature, repeatedly extracting filter residues with ethanol for three times, mixing the filtrates, pouring the filtrate into a round-bottom flask, adding 5-10 times of ethanol, shaking uniformly, filtering with a 0.45um filter membrane, and taking the filtrate to obtain the Aronia melanocarpa fruit-soybean beverage;
wherein, the Aronia melanocarpa fruit: and (3) soybean: the mass ratio of the lactobacillus plantarum OPB15 bacterial powder is 1:0.01:5.
further, the preparation method of the camel milk liposome in the step (1) comprises the following steps:
firstly, incubating camel milk at 35+/-1 ℃ for 10+/-1 min, continuously stirring, spin-drying water by a film dispersion method to form a honeycomb film, and performing ultrasonic treatment for 10+/-1 min under the pressure of 2500psi to prepare the camel milk liposome.
Further, the preparation method of the active polypeptide in the step (1) is as follows:
crushing hickory, wheat, peas, pollen pini and peach kernels, adding water, adjusting the pH value to be slightly alkaline pH=8.7+/-0.5, extracting protein by an alkali-dissolution acid precipitation method, freeze-drying, centrifuging at 8000rpm for 10 minutes after protease enzymolysis, and freeze-drying supernatant to obtain the active polypeptide extract.
Further, the tea tree essential oil and the clove essential oil have synergistic preservative effect, and are plant source preservatives.
The invention has the advantages and positive effects that:
1. the invention applies the active ingredients of the Aronia melanocarpa after fermentation to the design of skin care products such as eye cream and the like, mixes and encapsulates the active substances of the Aronia melanocarpa and the chamomile extract together by using a liposome technology, optimizes and screens the technological parameters of the liposome nanotechnology, and exerts the skin care effect to the greatest extent.
2. The invention applies the Aronia melanocarpa polysaccharide to the cosmetics for the first time to improve the antioxidation effect of the cosmetics, and the lactobacillus plantarum OPB15 is used for fermenting the products for the first time, and the fermenting products have stable and good effects, can enhance the antioxidation function and have excellent skin feel.
3. The Aronia melanocarpa polysaccharide used in the invention has the function of enhancing antioxidation. The Aronia melanocarpa polysaccharide is also applied to cosmetics for the first time.
4. The Aronia melanocarpa used by the invention has the effects of resisting oxidation, resisting aging, resisting radiation, relieving visual fatigue and the like. And organic acid generated by lactobacillus plantarum OPB15 used for fermentation in the fermentation process can prevent degradation of phenolic substances, so that the total phenolic content is increased. The acidic environment caused by the generated organic acid of the fermentation is favorable for stabilizing the phenolic substances. During fermentation, certain enzymes are produced, and polysaccharide and protein on the cell wall of the Sorbus nigra are hydrolyzed, so that phenolic substances combined with the polysaccharide and protein are released. Increasing its antioxidant capacity.
5. The eye cream has the effects of improving skin moisture, barrier function, tightening eye skin, relieving dark circles, improving wrinkles and fine lines, reducing edema and keeping skin fresh.
6. The eye cream of the invention uses liposomes as vehicles. Liposomes (lipomes) are miniature spherical carriers formed by encapsulating an active ingredient within a lipid bilayer, the soluble ingredient may be encapsulated in the inner aqueous phase of a phospholipid, and the lipid-soluble ingredient may be encapsulated between phospholipid bilayers. The liposome is a typical representative of a nano drug-carrying system, has passive targeting, protects the drug from being destroyed, increases the stability and the solubility of insoluble drugs, can control the release rate of the drug, prolongs the circulation time of the liposome in the body, and improves the curative effect of the drug. Is friendly to the sensitive people of the skin, and the finished product has no harmful chemical substances.
Drawings
FIG. 1 is a chromatogram of a mixed monosaccharide control of the present invention;
FIG. 2 is a chromatogram of the polysaccharide hydrolysis monosaccharide of Aronia melanocarpa according to the present invention;
FIG. 3 shows NaIO of different concentrations in the present invention 4 The standard curve is prepared;
FIG. 4 is a gas chromatogram of the present invention after standard derivatization;
FIG. 5 is a gas chromatogram of the invention after sample degradation derivatization;
FIG. 6 shows the polysaccharide of Aronia melanocarpa in the present invention 1 H NMR spectrum;
FIG. 7 shows the polysaccharide of Aronia melanocarpa in the present invention 13 C NMR spectrum;
FIG. 8 is a Fourier infrared plot of Aronia melanocarpa polysaccharide of the present invention;
FIG. 9 is a graph showing the molecular weight standards of the present invention for different molecular weight standards;
FIG. 10 is a differential chromatogram of Aronia melanocarpa polysaccharide of the present invention;
FIG. 11 is a solid state fermentation diagram of Aronia melanocarpa fruit fermented by Lactobacillus plantarum OPB15 according to the invention;
FIG. 12 shows ultraviolet and mass spectra (+) of unfermented Aronia melanocarpa;
FIG. 13 shows ultraviolet and mass spectra (-) of unfermented Aronia melanocarpa;
FIG. 14 shows the ultraviolet and mass spectrum (+) of Aronia melanocarpa fermented by Lactobacillus plantarum OPB15 according to the invention;
FIG. 15 is a graph showing the ultraviolet and mass spectra (-) of Aronia melanocarpa fermented by Lactobacillus plantarum OPB15 according to the invention;
FIG. 16 is a colony morphology of Lactobacillus plantarum OPB15 according to the invention;
FIG. 17 is a microscopic photograph of Lactobacillus plantarum OPB15 according to the invention;
FIG. 18 is a graph of BLAST results versus tree for the Lactobacillus plantarum OPB15 genomic sequence of the invention.
Detailed Description
The invention will now be further illustrated by reference to the following examples, which are intended to be illustrative, not limiting, and are not intended to limit the scope of the invention.
The various experimental operations involved in the specific embodiments are conventional in the art, and are not specifically noted herein, and may be implemented by those skilled in the art with reference to various general specifications, technical literature or related specifications, manuals, etc. before the filing date of the present invention.
The lactobacillus plantarum is lactobacillus plantarum OPB15, and the name of the lactobacillus plantarum is that of the lactobacillus plantarum is Aronia melanocarpa extract nanometer eye cream after lactobacillus plantarum fermentation: OPB15, class name: lactobacillus plantarum (Lactobacillus plantarum), accession number: CGMCC No.27735, date of preservation: 2023, 6, 29, deposit unit: china general microbiological culture Collection center, north Chen Xi Lu No. 1, 3, the Korean region of Beijing, and the China general microbiological culture Collection center.
The preparation method of the Aronia melanocarpa extract nanometer eye cream comprises the following steps of:
(1) Mixing active polypeptide, ginsenoside, flos Matricariae Chamomillae extract, aronia melanocarpa polysaccharide, and fermented Aronia melanocarpa extract with camel milk liposome under stirring, incubating at 35+ -1deg.C for 10+ -1 min, and continuously stirring; spin-drying water to form a honeycomb membrane, adding puer tea extract, dissolving the honeycomb membrane, and performing ultrasonic treatment for 10 minutes under the pressure of 2500psi to obtain camel milk liposome encapsulating active ingredients; heating camel milk liposome encapsulated with active ingredients to 70+/-1 ℃;
wherein the active polypeptide: ginsenoside: chamomile extract: aronia melanocarpa polysaccharide: and (3) fermenting the Aronia melanocarpa extract: camel milk liposome: the mass ratio of the puer tea extract is 1:1:1:2:3:8:1, a step of;
(2) Adding acacia and sodium alginate into water, stirring to obtain gel matrix, adding active ingredient-entrapped camel milk liposome into the gel matrix at 70+ -1deg.C, stirring to uniformity, and adding vitamin C and vitamin E; continuously stirring until the mixture is uniform, and preserving the temperature for 10+/-1 minutes to obtain a mixture;
wherein, acacia: sodium alginate: camel milk liposome encapsulating active ingredients: vitamin C: the mass ratio of the vitamin E is 1:1:4:1:1, a step of;
(3) Cooling the mixture to 30-45 ℃, adding ultrapure water into hyaluronic acid, trehalose, tea tree essential oil and clove essential oil, mixing, stirring uniformly, adding into the mixture prepared in the step (2), shaking uniformly, standing until no precipitate exists, adding ultrapure water and acacia gum, and regulating the viscosity of eye cream, thus obtaining the fermented black chokeberry extract nanometer eye cream;
wherein, hyaluronic acid: trehalose: tea tree essential oil: butyl essential oil: ultrapure water added for the first time: the mass ratio of the mixture prepared in the step (2) is 0.8:1:1:1:5:10.
preferably, the preparation method of the puer tea extract in the step (1) comprises the following steps:
weighing puer tea, crushing, and drying until the quality is unchanged, wherein the liquid-to-material ratio is 1:30 adding ultrapure water, heating and refluxing at 80 ℃ for 1.5 hours, cooling, vacuum filtering to obtain filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, freeze-drying in a freeze dryer, and freeze-drying into powder after 12 hours to obtain the puer tea extract.
Preferably, the preparation method of the chamomile extract in the step (1) comprises the following steps:
weighing stems and leaves of chamomile, drying until the mass is no longer changed, crushing into powder, and mixing according to a liquid-to-material ratio of 1:15 adding ultrapure water, heating and refluxing for 3 hours at 85 ℃, cooling, vacuum filtering to obtain a filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, freeze-drying in a freeze dryer, and freeze-drying into powder after 12 hours to obtain the chamomile extract.
Preferably, the preparation method of the ginsenoside in the step (1) comprises the following steps:
weighing ginseng, crushing, and drying until the quality is unchanged, wherein the liquid-to-material ratio is 1:10 adding ultrapure water, heating and refluxing at 77 ℃ for 3 hours, cooling, vacuum filtering to obtain filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, and then freeze-drying in a freeze dryer for 12 hours to obtain ginsenoside dry powder, thus obtaining the ginsenoside extract.
Preferably, the preparation method of the Aronia melanocarpa polysaccharide in the step (1) comprises the following steps:
1) Taking Aronia melanocarpa, placing in a filter paper bucket, folding the opening of the filter paper bucket, sealing, placing in a Soxhlet extractor, extracting with diethyl ether at 54 deg.C until the diethyl ether is clear, taking out the filter paper wrapped with black fruit, and placing in a fume hood to volatilize the residual diethyl ether;
2) Extracting black fruit with water at 77 deg.C for 90 min, precipitating with ethanol to obtain filtrate, extracting the residue once again, mixing the filtrates, and filtering to obtain clear liquid; concentrating, namely concentrating the Aronia melanocarpa to 10ml per 15g, and precipitating the Aronia melanocarpa with 92% ethanol overnight; centrifuging at 7000rpm for 10 min, removing supernatant, washing precipitate with diethyl ether and ethanol for 2 times, and dissolving with hot water after volatilizing solvent;
3) After the addition of sevage reagent (chloroform: the volume ratio of n-butanol is 4: 1) Deproteinizing, shaking for 30min, standing for separating protein, removing organic phase and protein between water phase and organic phase for 5-6 times; dialyzing with dialysis bag (MD 44-10000) for 12 hr, and lyophilizing to obtain Aronia melanocarpa polysaccharide.
Preferably, the preparation method of the Aronia melanocarpa extract after fermentation in the step (1) comprises the following steps:
taking Aronia melanocarpa fruits and soybeans, crushing, drying until the fruits are unchanged, sterilizing, adding sterile water to be sticky, adding lactobacillus plantarum OPB15 bacteria powder, shaking uniformly, culturing in a constant-temperature incubator for 48 hours, taking out, soaking with 5-10 times of ethanol, performing ultrasonic extraction, centrifuging, filtering to obtain filtrate, cooling to room temperature, repeatedly extracting filter residues with ethanol for three times, mixing the filtrates, pouring the filtrate into a round-bottom flask, adding 5-10 times of ethanol, shaking uniformly, filtering with a 0.45um filter membrane, and taking the filtrate to obtain the Aronia melanocarpa fruit-soybean beverage;
wherein, the Aronia melanocarpa fruit: and (3) soybean: the mass ratio of the lactobacillus plantarum OPB15 bacterial powder is 1:0.01:5.
preferably, the preparation method of the camel milk liposome in the step (1) comprises the following steps:
firstly, incubating camel milk at 35+/-1 ℃ for 10+/-1 min, continuously stirring, spin-drying water by a film dispersion method to form a honeycomb film, and performing ultrasonic treatment for 10+/-1 min under the pressure of 2500psi to prepare the camel milk liposome.
Preferably, the method for preparing the active polypeptide in the step (1) comprises the following steps:
crushing hickory, wheat, peas, pollen pini and peach kernels, adding water, adjusting the pH value to be slightly alkaline pH=8.7+/-0.5, extracting protein by an alkali-dissolution acid precipitation method, freeze-drying, centrifuging at 8000rpm for 10 minutes after protease enzymolysis, and freeze-drying supernatant to obtain the active polypeptide extract.
Preferably, the tea tree essential oil and the clove essential oil have synergistic preservative effect, and are plant source preservatives.
Specifically, the related preparation and detection are as follows:
comparative example 1
Vitamin C standard working solution: accurately weighing l0mg pure vitamin C, fully dissolving in 1ml ultrapure water to prepare 10mg/ml vitamin C solution, and carrying out gradient dilution to 20, 15, 10, 6 and 2ug/ml Vc standard working solution.
Example 1 unfermented Aronia melanocarpa extract was prepared as follows:
taking a certain amount of Aronia melanocarpa and a small amount of soybean, pulverizing, oven drying until no change occurs, sterilizing, adding a small amount of sterile water to a viscous state, adding a proper amount of lactobacillus plantarum OPB15 powder, shaking uniformly, immediately soaking with 5-10 times of ethanol, performing ultrasonic extraction and centrifugation, filtering to obtain filtrate, cooling to room temperature, repeatedly extracting filter residues with ethanol for three times, mixing the filtrates, pouring the filtrate into a round-bottom flask, adding ethanol to scale marks, shaking uniformly, filtering with a 0.45um filter membrane, and taking the filtrate to obtain the Aronia melanocarpa extract. Wherein, the Aronia melanocarpa fruit: and (3) soybean: the mass ratio of the lactobacillus plantarum OPB15 bacterial powder is 1:0.01:5
Example 2 the preparation method of the Aronia melanocarpa extract after fermentation is as follows:
taking the same amount of Aronia melanocarpa fruits and a small amount of soybeans as unfermented, crushing, drying until no change occurs, sterilizing, adding a small amount of sterile water to be sticky, adding a proper amount of lactobacillus plantarum OPB15 bacteria powder, shaking uniformly, culturing in a constant temperature incubator for 48 hours, taking out, immediately soaking with 5-10 times of ethanol, carrying out ultrasonic extraction, centrifuging, filtering to obtain filtrate, cooling to room temperature, repeatedly extracting filter residues with ethanol for three times, mixing the filtrates, pouring the filtrate into a round bottom flask, adding 5-10 times of ethanol, shaking uniformly, filtering with a 0.45um filter membrane, and taking the filtrate to obtain the Aronia melanocarpa fruit. Wherein, the Aronia melanocarpa fruit: and (3) soybean: the mass ratio of the lactobacillus plantarum OPB15 bacterial powder is 1:0.01:5.
example 3 preparation method of Aronia melanocarpa polysaccharide comprises the following steps:
1) 15g of Aronia melanocarpa is taken out in a filter paper bucket, the opening of the filter paper bucket is folded and sealed, and the filter paper bucket is put into a Soxhlet extractor and is treated with diethyl ether at 54 ℃. Extraction was started until the diethyl ether extracted was clear. The black fruit wrapped filter paper fume hood was removed and the remaining ether was evaporated to dryness.
2) And (5) extracting the black fruits with water and precipitating with ethanol after the black fruits are taken out from the fume hood. The temperature was 77℃for 90 minutes. And (3) extracting the filter residue once again, combining the two filtrates, filtering, and taking clear liquid. Concentrate to 10ml,92% ethanol was ethanol precipitated overnight. Centrifugation at 7000rpm for 10 min, the supernatant was discarded. The precipitate was washed 2 times with diethyl ether and ethanol, and dissolved in hot water after the solvent had evaporated.
3) After the addition of sevage reagent (chloroform: n-butanol=4: 1) Deproteinizing, then shaking for about 30min, standing for separating protein, removing organic phase and protein between aqueous phase and organic phase, and repeating for 5 to 6 times. Dialyzing with dialysis bag (MD 44-10000) for 12 hr, and lyophilizing to obtain black fruit polysaccharide.
EXAMPLE 4 preparation method of unfermented Aronia melanocarpa nanometer eye cream
(1) The active polypeptide, the ginsenoside, the chamomile extract, the Aronia melanocarpa polysaccharide prepared in example 3, the unfermented Aronia melanocarpa extract prepared in example 1 and the camel milk liposome are stirred and mixed uniformly, incubated for about 10 minutes at about 35 ℃, and stirred continuously. Spin-drying water to obtain honeycomb membrane, adding puer tea extract, dissolving the honeycomb membrane, and ultrasonic treating for 10 min under 2500psi to obtain camel milk liposome containing active ingredients. Heating camel milk liposome coated with active ingredients to about 70deg.C. Wherein the active polypeptide: ginsenoside: chamomile extract: the Aronia melanocarpa polysaccharide prepared in example 3: the unfermented Aronia melanocarpa extract prepared in example 1: camel milk liposome: the mass ratio of the puer tea extract is 1:1:1:2:3:8:1, a step of;
(2) Adding acacia and sodium alginate into water according to a certain proportion, stirring to obtain a gel matrix, adding active ingredient-entrapped camel milk liposome into the gel matrix at about 70deg.C, stirring to uniformity, and adding vitamin C and vitamin E. Continuously stirring until the mixture is uniform, and preserving the temperature for about 10 minutes to obtain a mixture; wherein, the mass ratio of the acacia, the sodium alginate, the camel milk liposome encapsulating the active ingredients, the vitamin C and the vitamin E is 1:1:4:1:1, a step of;
(3) And (3) reducing the temperature of the mixture to 30-45 ℃, adding ultrapure water into hyaluronic acid, trehalose, tea tree essential oil and clove essential oil, mixing, stirring uniformly, adding into the mixture prepared in the step (2), shaking uniformly, standing until no precipitate exists, adding a proper amount of ultrapure water and acacia to regulate the viscosity of the eye cream, and thus obtaining the unfermented Aronia melanocarpa nano eye cream. Wherein, hyaluronic acid: trehalose: tea tree essential oil: butyl essential oil: ultrapure water added for the first time: the mass ratio of the mixture prepared in the step (2) is 0.8:1:1:1:5:10.
wherein, the preparation method of the puer tea extract in the step (1) comprises the following steps:
weighing puer tea, crushing, and drying until the quality is unchanged, wherein the liquid-to-material ratio is 1:30 adding ultrapure water, heating and refluxing at 80 ℃ for 1.5 hours, cooling, vacuum filtering to obtain filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, freeze-drying in a freeze dryer, and freeze-drying into powder after 12 hours to obtain the puer tea extract.
The preparation method of the chamomile extract in the step (1) comprises the following steps:
weighing stems and leaves of chamomile, drying until the mass is no longer changed, crushing into powder, and mixing the liquid with the material in a ratio of 1:15 adding ultrapure water, heating and refluxing for 3 hours at 85 ℃, cooling, vacuum filtering to obtain a filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, freeze-drying in a freeze dryer, and freeze-drying into powder after 12 hours to obtain the chamomile extract.
The preparation method of the ginsenoside in the step (1) comprises the following steps:
weighing a proper amount of ginseng, crushing, and drying until the quality is unchanged, wherein the liquid-to-material ratio is 1:10 adding ultrapure water, heating and refluxing at 77 ℃ for 3 hours, cooling, vacuum filtering to obtain filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, and then freeze-drying in a freeze dryer for 12 hours to obtain ginsenoside dry powder, thus obtaining the ginsenoside extract.
The preparation method of the camel milk liposome in the step (1) comprises the following steps:
firstly, the camel milk is incubated at about 35 ℃ for about 10 minutes, and is continuously stirred to spin dry the water into a honeycomb membrane by a film dispersion method, and the camel milk liposome is prepared by ultrasonic treatment for about 10 minutes under the pressure of 2500 psi.
The camel milk liposome is diluted by 10-100 times with distilled water before being mixed with other active ingredients.
The preparation method of the active polypeptide in the step (1) comprises the following steps:
taking a certain amount of hickory, wheat, peas, pollen pini and peach kernels, crushing, adding water, adjusting the pH value to be slightly alkaline (pH=8.7), extracting protein by an alkali-dissolution acid precipitation method, freeze-drying, centrifuging at 8000rpm for 10 minutes after enzymolysis by protease, and freeze-drying supernatant to obtain the active polypeptide extract.
The tea tree essential oil and the clove essential oil have the functions of corrosion prevention and are plant source preservatives.
Example 5 preparation method of fermented Aronia melanocarpa nanometer eye cream comprises the following steps:
(1) The active polypeptide, the ginsenoside, the chamomile extract, the Aronia melanocarpa polysaccharide prepared in example 3 and the fermented Aronia melanocarpa extract prepared in example 2 are stirred and mixed uniformly, incubated for about 10 minutes at about 35 ℃, and stirred continuously. Spin-drying water to obtain honeycomb membrane, adding puer tea extract, dissolving the honeycomb membrane, and ultrasonic treating for 10 min under 2500psi to obtain camel milk liposome containing active ingredients. Heating camel milk liposome coated with active ingredients to about 70deg.C. Wherein the active polypeptide: ginsenoside: chamomile extract: the Aronia melanocarpa polysaccharide prepared in example 3: the fermented Aronia melanocarpa extract prepared in example 2: camel milk liposome: the mass ratio of the puer tea extract is 1:1:1:2:3:8:1, a step of;
(2) Adding acacia and sodium alginate into water according to a certain proportion, stirring to obtain a gel matrix, adding active ingredient-entrapped camel milk liposome into the gel matrix at about 70deg.C, stirring to uniformity, and adding vitamin C and vitamin E. Continuously stirring until the mixture is uniform, and preserving the temperature for about 10 minutes to obtain a mixture; wherein, the mass ratio of the acacia, the sodium alginate, the camel milk liposome encapsulating the active ingredients, the vitamin C and the vitamin E is 1:1:4:1:1, a step of;
(3) Cooling to 30-45deg.C, adding ultrapure water into hyaluronic acid, trehalose, tea tree essential oil and flos Caryophylli essential oil, mixing, stirring to uniformity, adding into the mixture prepared in step (2), shaking, standing until no precipitate exists, adding appropriate amount of ultrapure water and acacia to adjust viscosity of eye cream, and obtaining fermented Aronia melanocarpa nanometer eye cream. Wherein, hyaluronic acid: trehalose: tea tree essential oil: butyl essential oil: ultrapure water added for the first time: the mass ratio of the mixture prepared in the step (2) is 0.8:1:1:1:5:10.
the preparation method of the puer tea extract in the step (1) comprises the following steps:
weighing puer tea, crushing, and drying until the quality is unchanged, wherein the liquid-to-material ratio is 1:30 adding ultrapure water, heating and refluxing at 80 ℃ for 1.5 hours, cooling, vacuum filtering to obtain filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, freeze-drying in a freeze dryer, and freeze-drying into powder after 12 hours to obtain the puer tea extract.
The preparation method of the chamomile extract in the step (1) comprises the following steps:
weighing stems and leaves of chamomile, drying until the mass is no longer changed, crushing into powder, and mixing the liquid with the material in a ratio of 1:15 adding ultrapure water, heating and refluxing for 3 hours at 85 ℃, cooling, vacuum filtering to obtain a filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, freeze-drying in a freeze dryer, and freeze-drying into powder after 12 hours to obtain the chamomile extract.
The preparation method of the ginsenoside in the step (1) comprises the following steps:
weighing a proper amount of ginseng, crushing, and drying until the quality is unchanged, wherein the liquid-to-material ratio is 1:10 adding ultrapure water, heating and refluxing at 77 ℃ for 3 hours, cooling, vacuum filtering to obtain filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, and then freeze-drying in a freeze dryer for 12 hours to obtain ginsenoside dry powder, thus obtaining the ginsenoside extract.
The preparation method of the camel milk liposome in the step (1) comprises the following steps:
firstly, the camel milk is incubated at about 35 ℃ for about 10 minutes, and is continuously stirred to spin dry the water into a honeycomb membrane by a film dispersion method, and the camel milk liposome is prepared by ultrasonic treatment for about 10 minutes under the pressure of 2500 psi.
The camel milk liposome is diluted by 10-100 times with distilled water before being mixed with other active ingredients.
The preparation method of the active polypeptide in the step (1) comprises the following steps:
taking a certain amount of hickory, wheat, peas, pollen pini and peach kernels, crushing, adding water, adjusting the pH value to be about alkalescent pH=8.7, extracting protein by an alkali-dissolution acid precipitation method, freeze-drying, centrifuging at 8000rpm for 10 minutes after enzymolysis by protease, and freeze-drying supernatant to obtain the active polypeptide extract.
The tea tree essential oil and the clove essential oil have the functions of corrosion prevention and are plant source preservatives.
EXAMPLE 6 Aronia melanocarpa polysaccharide Structure
(1) Monosaccharide composition determination
1) Derivatization of a control: absorbing 400ul of mixed monosaccharide (mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, xylose and arabinose) solution, placing the mixed monosaccharide (mannose, rhamnose, glucuronic acid, glucose, galactose, xylose and arabinose) solution in a nut test tube according to the mass ratio of 1:1:1:1:1:1:1:1), sequentially adding 400ul of 0.3mol/L sodium hydroxide and 400ul of 0.5mol/L PMP solution, sealing, uniformly mixing, placing the mixture in a 70-DEG C water bath for 70min, taking out the mixture, cooling the mixture to room temperature, adding 400ul of 0.3mol/L hydrochloric acid to regulate the solution to be neutral, uniformly mixing the mixture, adding 1mL of chloroform to extract three times to remove PMP, taking out a water layer, and filtering the mixture by a 0.45um filter membrane.
2) Hydrolysis of Aronia melanocarpa polysaccharide: the Aronia melanocarpa polysaccharide prepared in example 3 was dissolved, placed in a screw flask, 1mL of trifluoroacetic acid was added, and the mixture was uniformly mixed and hydrolyzed at 120℃for 4.5 hours. Taking out and cooling after hydrolysis. Evaporated to dryness in a water bath at 80℃and 1mL of methanol was added thereto to remove trifluoroacetic acid. This procedure was repeated three times. The residue was dissolved in water under heating.
3) Polysaccharide PMP derivatization and reference derivatization: absorbing 400ul of the hydrolysis liquid of the Aronia melanocarpa polysaccharide prepared in the example 3, placing the hydrolysis liquid into a nut test tube, sequentially adding 400ul of 0.3mol/L sodium hydroxide and 400ul of 0.5mol/L PMP solution, sealing, uniformly mixing, placing the mixture into a water bath kettle at 70 ℃ for 70min, taking out, cooling to room temperature, adding 400ul of 0.3mol/L hydrochloric acid to adjust the solution to be neutral, uniformly mixing, adding 1mL of chloroform to extract for three times to remove PMP, taking out a water layer, and filtering with a 0.45um filter membrane.
4) Chromatographic conditions: inertSustatin C18 column (4.6X250 mm,5 um). Acetonitrile-0.05 mol/L phosphate buffer (pH=6.8) as mobile phase, flow rate of 1mL/min, detection wavelength of 254nm, column temperature of 35 and sample injection amount of 10ul.
Conclusion: the fructus Piperis has eight monosaccharide chromatographic peaks, which are respectively mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, xylose, and arabinose (shown in figures 1 and 2). The external standard method calculates the molar ratio of each monosaccharide by peak area, and the molar ratio of each saccharide is: 1.93:0.87:0.86:1.99:27.27:3.36:1.75:1.48.
(2) Periodate oxidation and Smith degradation
1) Standard curve establishment: preparing 30mmol/LNaIO4, packaging with current tinfoil, taking 6 dry test tubes, sequentially adding 30mmol/LNaIO4 solution 0, 0.5, 1, 1.5, 2 and 4mL, mixing and shaking the test tubes uniformly, taking 0.1mL to 25mL volumetric flasks for each tube, fixing the volume, and measuring the OD value at 223 nm. The abscissa represents concentration, the ordinate represents absorbance, and a standard curve (see fig. 3) is drawn.
2) Oxidation of periodic acid: 12.5mg of example 3 were weighed, dissolved in 12.5ml of ultrapure water, put into a 25ml volumetric flask, and NaIO at a concentration of 15mmol/L was added 4 . The OD value was measured at 223nm by shaking reaction in a flask of 100ul to 25ml in 0, 7, 12, 24, 48, 72, 96h with a pipette, respectively, to a constant volume with ultrapure water, at room temperature until the OD value was no longer changed.
3) Terminating the reaction: when the OD value was not changed, 2ml of ethylene glycol was added to the reaction system to terminate the reaction. And allowed to stand for 20min. 2ml of the reaction solution was removed by a pipette, and the amount of formic acid released was determined by dropping with 0.01mol/L NaOH standard solution using phenolphthalein as an indicator. The remainder was transferred to dialysis bag (3000 Da) for dialysis.
4) Smith degradation: and (3) dialyzing for 60 hours, changing water once for 4 hours, concentrating to about 10mL under reduced pressure after dialyzing, adding 70mg of sodium borohydride, uniformly mixing and reacting for 24 hours in a dark place. After the reaction is completed, 50% acetic acid solution (v/v) is dripped to adjust the PH to 5-7, the ultrapure water is dialyzed for 60 hours, water is replaced for 4 hours as much as possible, and the dialysate is evaporated to dryness under reduced pressure after dialysis. 10mg hydroxylamine hydrochloride and 1mL pyridine were added and the reaction was continued with shaking in a 90℃water bath for 30min until the precipitate disappeared. After cooling to room temperature, adding 1mL of acetic anhydride, carrying out oscillation reaction for 30min in a 90-DEG water bath, taking out, cooling to room temperature, finally generating the volatile sugar nitrile acetate derivative, adding 1mL of chloroform, and then carrying out GC analysis by 0.22um coating (shown in figures 4 and 5).
Conclusion: 1mol of hexose consumed 1.42mol of periodic acid to produce 0.6493 formic acid indicated that it contained 64.93% of 1-or 1-6 bonds (ortho-trihydroxy), 12.14% of 1-2, 1-2.6,1-4 or 1-2.4 glycosidic bonds (ortho-dihydroxyl) and 22.93% of 1-3, 1-3.4,1-3.6,1-2.4,1-2.3,1-2.3.4 glycosidic bonds (and no ortho-trihydroxy nor ortho-dihydroxyl).
The products of the Aronia melanocarpa after Smith degradation include glycerol, erythritol and ethylene glycol. Indicating the presence of a large number of 1.fwdarw.6, 1.fwdarw.1.fwdarw.2, 1.fwdarw.2, 6, 1.fwdarw.4 or 1.fwdarw.4, 6 glycosidic bonds;
the product contains a small amount of mannose and glucose, which indicates that the Sorbus nigra contains non-oxidized 1-3, 1-2, 3, 1-3, 6, 1-2, 4, 1-2, 3,4 glycosidic bonds; the existence of mannose and glucose indicates that the mannose and the glucose contain non-oxidized glycosidic bonds, rhamnose is detected in degradation products, the partial rhamnose is not oxidized by periodic acid, and the conclusion that a part of connecting bonds in the Sorbus nigra are 1-2 or 1-2, 6 is made; galactose was detected in the Smith degradation products, indicating that the black fruit contained 1.fwdarw.3, 1.fwdarw.2, 3, 1.fwdarw.2, 4, 1.fwdarw.3, 6 or 1.fwdarw.2, 3,4 glycosidic linkages, i.e., galactose residues.
(3) Nuclear magnetic resonance measurement
15mg of the Aronia melanocarpa polysaccharide sample prepared in example 3 was weighed and dissolved in 1mLD 2 O, go through 1 H and 13 determination of C spectra
Conclusion: in comparison with other natural components, the saccharide is 1 The signals in HNMR spectra are within a very narrow range, the polysaccharide signals are generally concentrated in the delta 3.0-6.0 range, and more than 5.0ppm of alpha-configuration pyranose is generally smallAt 5.0ppm is beta-configuration pyranose. The 1H NMR spectrum of Aronia melanocarpa polysaccharide shows that the signal of the hydrogen at different heads appears at delta 5.0-6.0, so that Aronia melanocarpa polysaccharide has alpha-configuration glycosidic bond (shown in figure 6).
Sugar is in 13 The signal of the terminal carbon in the C NMR spectrum is within the range of delta 95-110 ppm. The delta values of the alpha-D and beta-L type glycosidic linkages of monosaccharides are typically less than 100ppm, and the delta values of the alpha-L and beta-D type glycosidic linkages are typically greater than 100ppm, which can be reduced to delta 98ppm in the case of tertiary alcohol and ester glycosides, and individual phenolic glycosides. Thus, according to polysaccharide 13 The number of saccharides and the configuration of glycosidic linkages in the polysaccharide are deduced from the number of carbon signals and the delta value in the range of delta 95-110ppm in the C NMR spectrum. The signal of the exocarpium of Aronia melanocarpa polysaccharide has 2 absorption peaks in the delta 95-110ppm range, and it is presumed that 2 sugar residues exist in the repeating unit of the polysaccharide sugar chain in Aronia melanocarpa polysaccharide. The peak of the signal of the anomeric carbon in the range of delta 70-80ppm is a characteristic peak of the pyran ring (see FIG. 7).
(4) Fourier infrared measurement
Taking the Aronia melanocarpa polysaccharide prepared in example 3 and dry KBr according to the mass of 1:100, fully grinding, tabletting and infrared 4000-400 cm -1 Scanning is carried out in the wave band.
Conclusion: at 3415cm -1 The absorption peak shown there may be a telescopic vibration absorption peak of O-H; 2925cm -1 The weak absorption peak at the point may be a C-H bending vibration absorption peak; 1650cm -1 Bending vibration absorption peaks which may be O-H; 1375cm -1 A variable angle vibration peak which may be C-H; 1032cm -1 A bending vibration absorption peak which may be a C-O-C connection; 1200-1000cm -1 Peaks indicate that it is likely to be a pyran polysaccharide; and at 882cm -1 The absorption peaks of (a) indicate that they may be linked by β -type glycosidic linkages (see fig. 8).
(5) Determination of polysaccharide molecular weight of Aronia melanocarpa
Chromatographic conditions: the experiment adopts high-efficiency GEL permeation chromatography to determine the molecular weight distribution of Aronia melanocarpa polysaccharide, and the chromatographic column is TSK-GEL G4000 PWXL GEL column (7.8 mm×30.0 cm). The mobile phase is ultrapure water; the flow rate is 0.8mL/min; the column temperature is 35 ℃; the detector used was a differential refractive detector.
Establishing a molecular weight correction standard curve: dextran standard substances with different molecular weights are matched into standard liquid with the concentration of 1.0mg/mL by using a mobile phase, and the sample injection amount is 1g/L. Molecular weight standard curves were prepared (FIG. 9).
The retention time was calculated by sampling 1g/L of the Aronia melanocarpa polysaccharide solution (FIG. 10), and the retention time was calculated to give a molecular weight of Mr= 10876Da by the formula Qu Gong.
Example 7: screening of Lactobacillus plantarum OPB15
Isolation and screening of Lactobacillus
(1) 0.1ml of a yogurt sample (from the home self-brewed yogurt of the farmers in the Awa-tikou province of Kaisha) was inoculated into a skim milk medium and placed in a 37℃incubator for 48h. A small amount of bacterial liquid is picked by an inoculating loop, streaked and inoculated in an MRS agar culture medium plate.
(2) After 48 hours, different colonies are picked up by an inoculating loop according to the shape, size, color and the like of the colonies, and streaked separation and purification are carried out.
(3) Gram-positive bacteria and catalase-negative bacteria were retained by gram staining and catalase analysis.
(4) Obtaining thallus and colony characteristics of the final strain: gram-positive rod-shaped bacteria, non-sporulating, non-motile bacteria (fig. 16); the diameter is about 1.0-1.2 mm, the front face is round, the center is convex, the edge is neat, the surface is moist and smooth, milky white, opaque and slightly sour (figure 17).
Molecular biological identification of Lactobacillus
(1) Single genome extraction
(A) Culturing the screened lactobacillus overnight;
(B) Using a Soxhaust bacteria genome DNA extraction kit, the product number is 1600, taking 1ml of the bacterial suspension cultured overnight, centrifuging in a 1.5ml centrifuge tube at 12000r/min for 1min, and sucking out the supernatant as much as possible;
(C) Adding 200ul of lysozyme with a final concentration of 20mg/ml into thalli, and treating for 40min at 37 ℃;
(D) Adding solution A (10 mmol/L, pH =8.0 Tris-HCl and 1mmol/L EDTA mixed solution, SDS with concentration of 0.08g/mL and NaCl with concentration of 1.5 mol/L) into the mixed solution obtained in the step (C), blowing by a pipette to fully suspend the thalli, adding 20ul rNaseA (10 mg/mL) into the suspension, fully reversing and uniformly mixing, and standing at room temperature for 30min;
(E) Adding 20ul proteinase K into the tube, mixing well, and digesting at 55deg.C for 60min; inverting the centrifuge tube for several times during digestion until the sample is clear and viscous, and proving that the sample is completely digested;
(F) Adding 200ul of solution B (mixed solution of phenol and isoamyl alcohol=25:24:1 by volume ratio) into the inquiry tube, fully inverting and uniformly mixing, if white precipitation appears, standing at 75 ℃ for 15-30min, wherein the precipitation can disappear;
(G) Adding 200ul of absolute ethyl alcohol into a tube, fully and uniformly mixing, wherein flocculent precipitate can be generated at the moment without influencing DNA extraction, adding the solution and the flocculent precipitate into an adsorption column, and standing for 2min;
(H) Centrifuging at 12000rpm for 2min, discarding the waste liquid, and placing the adsorption column into a collecting pipe;
(I) Adding 600ul of rinsing liquid (75% ethanol) into the adsorption column, centrifuging at 12000rpm for 1min, discarding the waste liquid, placing the adsorption column into a collecting pipe, and repeating for one time;
(J) Centrifuging at 12000rpm for 2min, and placing the adsorption column in a 50 deg.C incubator for several minutes;
(K) Placing the adsorption column into a sterilized 1.5ml centrifuge tube, suspending and dripping 100ul of the washing liquid (general purpose) preheated by 65 ℃ water bath into the center of the adsorption film, standing for 5min at room temperature, and centrifuging for 1min at 12000 rpm;
and (L) adding the eluent obtained by centrifugation into an adsorption column, standing for 2min at room temperature, and centrifuging at 12000rpm for 2min to obtain the genome DNA of the lactobacillus.
TTAGGCGGCTGGTTCCTAAAAGGTTACCCCACCGACTTTGGGTGTTACAAACTCTCATGGTGTGACGGGCGGTGTGTACAAGGCCCGGGAACGTATTCACCGCGGCATGCTGATCCGCGATTACTAGCGATTCCGACTTCATGTAGGCGAGTTGCAGCCTACAATCCGAACTGAGAATGGCTTTAAGAGATTAGCTTACTCTCGCGAGTTCGCAACTCGTTGTACCATCCATTGTAGCACGTGTGTAGCCCAGGTCATAAGGGGCATGATGATTTGACGTCATCCCCACCTTCCTCCGGTTTGTCACCGGCAGTCTCACCAGAGTGCCCAACTTAATGCTGGCAACTGATAATAAGGGTTGCGCTCGTTGCGGGACTTAACCCAACATCTCACGACACGAGCTGACGACAACCATGCACCACCTGTATCCATGTCCCCGAAGGGAACGTCTAATCTCTTAGATTTGCATAGTATGTCAAGACCTGGTAAGGTTCTTCGCGTAGCTTCGAATTAAACCACATGCTCCACCGCTTGTGCGGGCCCCCGTCAATTCCTTTGAGTTTCAGCCTTGCGGCCGTACTCCCCAGGCGGAATGCTTAATGCGTTAGCTGCAGCACTGAAGGGCGGAAACCCTCCAACACTTAGCATTCATCGTTTACGGTATGGACTACCAGGGTATCTAATCCTGTTTGCTACCCATACTTTCGAGCCTCAGCGTCAGTTACAGACCAGACAGCCGCCTTCGCCACTGGTGTTCTTCCATATATCTACGCATTTCACCGCTACACATGGAGTTCCACTGTCCTCTTCTGCACTCAAGTTTCCCAGTTTCCGATGCACTTCTTCGGTTGAGCCGAAAGCTTTCACATCAGACTTAAAAAACCGCCTGCGCTCGCTTTACGCCCAATAAATCCGGACAACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAGTAGCCGTGGCTTTCTGGTAATACCGTCATACCTGAACAGTTACTCTCAGATATGTTCTTCTTTAACAACNGAGTTTTACGAGCCGAAACCCTTCTCACTGCTATACATGCAAGTCGAACGAACTCTGGTATTGATTGGTGCTTGCATCATGATTTACATTTCGAGTGAGTGGCGAACTGGTGAGTAACACGTGGGAAACCTGCCCAGAAGCGGGGGATAACACCTGGAAACAGATGCTAATACCGCATAACAACTTGGACCGCATGGTCCGAGTTTGAAAGATGGCTTCGGCTATCACTTTTGGATGGTCCCGCGGCGTATTAGCTAGATGGTGGGGTAACGGCTCACCATGGCAATGATACGTAGCCGACCTGAGAGGGTAATCGGCCACATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCACAATGGACGAAAGTCTGATGGAGCAACGCCGCGTGAGTGAAGAAGGGTTTCGGCTCGTAAAACTCTGTTGTTAAAGAAGAACATATCTGAGAGTAACTGTTCAGGTATTGACGGTATTTAACCAGAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGATTTATTGGGCGTAAAGCGAGCGCAGGCGGTTTTTTAAGTCTGATGTGAAAGCCTTCGGCTCAACCGAAGAAGTGCATCGGAAACTGGGAAACTTGAGTGCAGAAGAGGACAGTGGAACTCCATGTGTAGCGGTGAAATGCGTAGATATATGGAAGAACACCAGTGGCGAAGGCGGCTGTCTGGTCTGTAACTGACGCTGAGGCTCGAAAGTATGGGTAGCAAACAGGATTAGATACCCTGGTAGTCCATACCGTAAACGATGAATGCTAAGTGTTGGAGGGTTTCCGCCCTTCAGTGCTGCAGCTAACGCATTAAGCATTCCGCCTGGGGAGTACGGCCGCAAGGCTGAACTCAAGGAATTGACGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCTACGCGAAGACCTTACCNNTCTGACATACTATGCAAATCTAGAGAT
(2)16S r DNA PCR
Bacterial 16S r DNA 50. Mu. LPCR reaction System: 24 mu L of Taq enzyme; dd H 2 O: 18. Mu.L; 27F, 2. Mu.L; 1492R, 2. Mu.L; and (3) a template: 4. Mu.L.
PCR conditions: 94℃for 5min (i.e.step 1); 94℃for 30s (i.e.step 2); 55℃for 30s (i.e.step 3); 30s at 72 ℃ (i.e. step 4); step2 to 4 30×; and at 72℃for 5min.
Preparing 1% agarose gel, mixing the PCR product with 10000×loading buffer, loading 2 μl, running at 120V for 30min, and performing gel imaging;
the obtained PCR product was sent to a professional sequencing company, and the obtained sequencing result was subjected to searching and similarity alignment in Gen Bank using BLAST (see FIG. 18), and identified as a strain of Lactobacillus plantarum, and stored at-80 ℃.
Example 8: lactobacillus plantarum OPB15 has good tolerance to simulated gastrointestinal fluids
In vitro simulated gastric fluid: the pH value of the 0.1mol/L potassium phosphate buffer solution is regulated to 2.5, pepsin (10 g/L) is added, and the mixture is uniformly mixed and then passes through a 0.22 mu m sterile film, so that simulated gastric juice can be obtained.
In vitro simulated intestinal juice: the pH value of the 0.1mol/L potassium phosphate buffer solution is regulated to 6.8, pancreatin (10 g/L) and pig bile salt (3 g/L) are added, and the mixture is uniformly mixed and then passes through a 0.22 mu m sterile film, thus obtaining the simulated intestinal juice.
Gastric digestion was simulated:
3.0mL of lactobacillus plantarum OPB15 culture solution is taken and centrifuged for 3min, mycelium is collected and placed in 3.0mL of gastric juice simulating environment with pH value of 2.5, and gastric juice digestion is simulated under anaerobic condition at 37 ℃ and 90 r/min. Samples were taken at 0, 1.0, 2.0, 3.0 hours, viable bacteria were counted using a dilution-coated plate count method, and survival rates were calculated.
Intestinal digestion was simulated:
centrifuging 3.0mL of lactobacillus plantarum OPB15 culture solution for 3min, collecting mycelium, and placing in 3.0mL of simulated intestinal juice environment with pH value of 6.8 at 37 ℃ under anaerobic condition of 120r/min to simulate intestinal juice digestion. Samples were taken at 0, 2.0, 4.0, 6.0, 8.0 hours, viable bacteria were counted using a dilution-coated plate count method, and survival rates were calculated.
The survival rate (%) was calculated as the ratio of the number of viable bacteria at the time of sampling to the number of viable bacteria at the time of 0h in the culture solution, expressed as%. The experimental results are shown in table 1, and the results show that lactobacillus plantarum OPB15 has better tolerance to artificial simulated gastrointestinal fluids.
TABLE 1 tolerance of Lactobacillus plantarum OPB15 in artificial simulated gastric fluid
TABLE 2 tolerance of Lactobacillus plantarum OPB15 in artificially simulated intestinal juice
Example 9: lactobacillus plantarum OPB15 has no toxic or side effect on SFP-class Balb/c mice
Suspending Lactobacillus plantarum OPB15 in 100g/L skim milk solution to give 4.0X10 g concentration 9 Bacterial suspension of CFU/m L. SPF-class Balb/c mice are bred in an environment with 40 males, the body mass of 18-22 g, the temperature of 20-25 ℃ and the relative humidity (50+/-5)%, and the illumination time of 12h/12 h. The lactobacillus plantarum OPB15 group and the control group are divided. The lactobacillus plantarum OPB15 group was given 0.3mL of this concentrated bacterial suspension once daily for gavage, and the control group was gavaged with the same volume of 100g/L skim milk solution without lactobacillus plantarum OPB15, and the death and weight were recorded for one week.
The results of these tests are shown in Table 3. These results indicate that the feeding concentration is 1.2X10 9 The CFU/lactobacillus plantarum OPB15 has no obvious influence on mice, no obvious change of weight and no death phenomenon. The appearance of the mice has no obvious pathological symptoms.
TABLE 3 weight changes and death in mice
The correlation detection is as follows:
1. antioxidant ability evaluation- -DPPH radical scavenging experiment
1. The unfermented Aronia melanocarpa extract prepared in example 1 was diluted to a certain concentration, and mixed with a nitrogen radical extract at a ratio of 1:9, and centrifuging at 1000rpm for 10min, collecting supernatant, and storing at 4deg.C.
2. The fermented Aronia melanocarpa extract prepared in example 2 was diluted to the same concentration as the unfermented Aronia melanocarpa extract prepared in example 1, and the concentration was adjusted to 1:9, and centrifuging at 1000rpm for 10min, collecting supernatant, and storing at 4deg.C.
3. 10mg/ml vitamin C solution is diluted to 20, 15, 10, 8, 6, 4 and 2ug/ml Vc standard working solution by nitrogen free radical extracting solution.
4. A blank tube, a sample measuring tube, a positive control tube and a solution were set in the above order according to Table 4, and the mixture was stirred uniformly and allowed to stand at room temperature for 30 minutes.
TABLE 4 description of the addition of substances to the tubes
5. The experimental group comprises fermented Aronia melanocarpa ethanol solution and unfermented Aronia melanocarpa ethanol solution; control group comparative example 1 (vitamin C ethanol solution)
6. Taking a 96-well plate, sequentially sucking 300ul of each tube of solution into the 96-well plate, and detecting absorbance values (517 nm) of each tube by using an enzyme-labeled instrument, and sequentially marking the absorbance values as A0, A1, A2 and A3.
7. Positive control DPPH clearance (%) = (A0-A3)/A0 x 100%
8. DPPH clearance (%) = [ A0- (A1-A2) ]/A0 of the sample to be tested is 100%
9. Wherein: a0 Absorbance values for the blank tube. A1 Absorbance values of the tube were measured for the samples. A2 Absorbance values for the control tube of the samples. A3 Absorbance of a positive control tube.
10. The above experimental results were repeated 3 times in parallel, i.e., n=3.
TABLE 5 evaluation results of the ability of vitamin C to clear DPPH
The Vc standard working solution has good linear relation at the speed of 2-8 ug/ml.
TABLE 6 evaluation results of DPPH-removing ability of fermented Aronia melanocarpa ethanol solution and unfermented Aronia melanocarpa ethanol solution
From Table 6, it can be seen that the fermented Aronia melanocarpa ethanol solution has a higher oxidation resistance than the unfermented Aronia melanocarpa ethanol solution.
2. Mass spectrum test of Aronia melanocarpa after fermentation and unfermented
1. The unfermented Aronia melanocarpa extract prepared in example 1 was diluted to a certain concentration, centrifuged at 1000rpm for 10min, and the supernatant was kept for use and 4 ℃ for further use.
2. The fermented Aronia melanocarpa extract prepared in example 2 was diluted to a certain concentration, centrifuged at 1000rpm for 10min, and the supernatant was kept for use at 4 ℃.
Liquid phase conditions:
instrument: waters HClass
Mobile phase: 0.1% formic acid B0.1% formic acid acetonitrile
Chromatographic column: waters BEH C181.7um 2.1 x 50um
Column temperature: 40 DEG C
TABLE 7 gradient elution
Time (min) | Flow rate (ml/min) | A(%) | B(%) |
0 | 0.4 | 95 | 5 |
1 | 0.4 | 95 | 5 |
35 | 0.4 | 2 | 98 |
37 | 0.4 | 2 | 98 |
37.1 | 0.4 | 95 | 5 |
40 | 0.4 | 95 | 5 |
Mass spectrometry conditions:
instrument: waters G2-XS Qtof
Positive mode: the voltage is 2kv, the ion source temperature is 110 ℃, the desolvation temperature is 400 ℃, the nitrogen flow rate is 800L/h, the acquisition mass number range is 50-1200, and the collision voltage is 20-40v.
Negative mode: the voltage is 1.5kv, the ion source temperature is 110 ℃, the desolvation temperature is 400 ℃, the nitrogen flow rate is 800L/h, the acquisition mass number range is 50-1200, and the collision voltage is 20-40v.
Table 8 mass spectral results
As can be seen from fig. 11 to 15 and table 8:
1. fig. 11-15 are total ion flow diagrams in positive and negative ion modes, and the total ion peak patterns in the positive and negative ion modes are symmetrical and have no obvious overlapping phenomenon, which shows that under the test conditions, the chemical composition of the dried sakura product can be well measured.
2. The chemical components of Aronia melanocarpa fruit mainly comprise flavonoids, anthocyanin, triterpenes, phenolic acids, sterols, sugar and glycosides.
3. The fructus Sorbi Pohuashanensis has high anthocyanin content, about 25% of total phenol content, and the main substances are 3-oxo-arabinoside, 3-oxo-glucoside, 3-oxo-xyloside, and 3-oxo-galactoside.
4. The accumulated polyphenol in the Aronia melanocarpa fruits is mainly synthesized by anthocyanin and glycoside compounds thereof.
5. The Aronia melanocarpa fruit contains abundant anthocyanin, and the proportion of the anthocyanin can reach about 25% of phenolic compounds. Anthocyanin is a common chemical component in natural plants. The anthocyanin can be hydrolyzed to the anthocyanidin under acidic conditions.
6. The flavonoid compound is mainly composed of quercetin and derivatives thereof, and the quercetin derivatives are mainly composed of isoquercetin and the like.
7. Organic acids produced during fermentation can prevent degradation of phenolic substances and thus lead to an increase in total phenol content. The acidic environment is favorable for stabilizing phenolic substances
8. The polysaccharide and protein on the cell wall of the Sorbus nigra are hydrolyzed by certain enzymes generated in the fermentation, so that the phenolic substances combined with the polysaccharide and protein are released, which may cause the improvement of the phenols.
Test example 3 sensory evaluation test of product:
two common eye creams were commercially available as control groups in examples 4 and 5 as experimental groups. Volunteers (25-55 years old) were selected 15 men and women each, and were randomized to average 3 groups, and after daily skin cleansing, the experimental and control groups were applied around the eyes and the effect was observed after 15 days. The different items were scored (0-100 points) according to skin condition changes, and the results are shown in table 9.
Table 9 evaluation results
Example 5 | Example 4 | Control group 1 | Control group 2 | |
Moisture retention | 96.32±2.43 | 91.32±1.42 | 84.89±3.01 | 85.64±2.52 |
Refreshing property | 98.56±2.12 | 95.65±1.67 | 85.56±1.24 | 91.83±1,53 |
Permeability of | 95.12±1.23 | 91.22±1.82 | 87.37±2.11 | 87.47±1.22 |
Wrinkle change | 90.88±1.81 | 87.73±1.94 | 81.47±1.01 | 83.28±0.81 |
Edema changes | 91.56±0.21 | 89.31±0.22 | 79.84±0.31 | 86.96±0.11 |
Skin color change | 81±0.23 | 79±1.22 | 77±0.12 | 77±0.21 |
Comfort level | 94±0.09 | 93±0.02 | 91±0.41 | 91±1.00 |
By combining the results, the Aronia melanocarpa liposome prepared by the invention is better than eye cream on the market, and each effect of the Aronia melanocarpa liposome after fermentation is optimal.
Although embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that: various substitutions, changes and modifications are possible without departing from the spirit and scope of the invention and the appended claims, and therefore the scope of the invention is not limited to the disclosure of the embodiments.
Claims (10)
1. A black chokeberry extract nanometer eye cream fermented by lactobacillus plantarum is characterized in that: the lactobacillus plantarum is lactobacillus plantarum OPB15, and the name of the lactobacillus plantarum is: OPB15, class name: lactobacillus plantarum (Lactobacillus plantarum), accession number: CGMCC No.27735, date of preservation: 2023, 6, 29, deposit unit: china general microbiological culture Collection center, north Chen Xi Lu No. 1, 3, the Korean region of Beijing, and the China general microbiological culture Collection center.
2. The method for preparing the black chokeberry extract nanometer eye cream according to claim 1, which is characterized in that: the method comprises the following steps:
(1) Mixing active polypeptide, ginsenoside, flos Matricariae Chamomillae extract, aronia melanocarpa polysaccharide, and fermented Aronia melanocarpa extract with camel milk liposome under stirring, incubating at 35+ -1deg.C for 10+ -1 min, and continuously stirring; spin-drying water to form a honeycomb membrane, adding puer tea extract, dissolving the honeycomb membrane, and performing ultrasonic treatment for 10 minutes under the pressure of 2500psi to obtain camel milk liposome encapsulating active ingredients; heating camel milk liposome encapsulated with active ingredients to 70+/-1 ℃;
wherein the active polypeptide: ginsenoside: chamomile extract: aronia melanocarpa polysaccharide: and (3) fermenting the Aronia melanocarpa extract: camel milk liposome: the mass ratio of the puer tea extract is 1:1:1:2:3:8:1, a step of;
(2) Adding acacia and sodium alginate into water, stirring to obtain gel matrix, adding active ingredient-entrapped camel milk liposome into the gel matrix at 70+ -1deg.C, stirring to uniformity, and adding vitamin C and vitamin E; continuously stirring until the mixture is uniform, and preserving the temperature for 10+/-1 minutes to obtain a mixture;
Wherein, acacia: sodium alginate: camel milk liposome encapsulating active ingredients: vitamin C: the mass ratio of the vitamin E is 1:1:4:1:1, a step of;
(3) Cooling the mixture to 30-45 ℃, adding ultrapure water into hyaluronic acid, trehalose, tea tree essential oil and clove essential oil, mixing, stirring uniformly, adding into the mixture prepared in the step (2), shaking uniformly, standing until no precipitate exists, adding ultrapure water and acacia gum, and regulating the viscosity of eye cream, thus obtaining the fermented black chokeberry extract nanometer eye cream;
wherein, hyaluronic acid: trehalose: tea tree essential oil: butyl essential oil: ultrapure water added for the first time: the mass ratio of the mixture prepared in the step (2) is 0.8:1:1:1:5:10.
3. the preparation method according to claim 2, characterized in that: the preparation method of the puer tea extract in the step (1) comprises the following steps:
weighing puer tea, crushing, and drying until the quality is unchanged, wherein the liquid-to-material ratio is 1:30 adding ultrapure water, heating and refluxing at 80 ℃ for 1.5 hours, cooling, vacuum filtering to obtain filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, freeze-drying in a freeze dryer, and freeze-drying into powder after 12 hours to obtain the puer tea extract.
4. The preparation method according to claim 2, characterized in that: the preparation method of the chamomile extract in the step (1) comprises the following steps:
weighing stems and leaves of chamomile, drying until the mass is no longer changed, crushing into powder, and mixing according to a liquid-to-material ratio of 1:15 adding ultrapure water, heating and refluxing for 3 hours at 85 ℃, cooling, vacuum filtering to obtain a filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, freeze-drying in a freeze dryer, and freeze-drying into powder after 12 hours to obtain the chamomile extract.
5. The preparation method according to claim 2, characterized in that: the preparation method of the ginsenoside in the step (1) comprises the following steps:
weighing ginseng, crushing, and drying until the quality is unchanged, wherein the liquid-to-material ratio is 1:10 adding ultrapure water, heating and refluxing at 77 ℃ for 3 hours, cooling, vacuum filtering to obtain filtrate, repeatedly extracting filter residues for three times, combining the filtrates, pre-freezing, and then freeze-drying in a freeze dryer for 12 hours to obtain ginsenoside dry powder, thus obtaining the ginsenoside extract.
6. The preparation method according to claim 2, characterized in that: the preparation method of the Aronia melanocarpa polysaccharide in the step (1) comprises the following steps:
1) Taking Aronia melanocarpa, placing in a filter paper bucket, folding the opening of the filter paper bucket, sealing, placing in a Soxhlet extractor, extracting with diethyl ether at 54 deg.C until the diethyl ether is clear, taking out the filter paper wrapped with black fruit, and placing in a fume hood to volatilize the residual diethyl ether;
2) Extracting black fruit with water at 77 deg.C for 90 min, precipitating with ethanol to obtain filtrate, extracting the residue once again, mixing the filtrates, and filtering to obtain clear liquid; concentrating, namely concentrating the Aronia melanocarpa to 10ml per 15g, and precipitating the Aronia melanocarpa with 92% ethanol overnight; centrifuging at 7000rpm for 10 min, removing supernatant, washing precipitate with diethyl ether and ethanol for 2 times, and dissolving with hot water after volatilizing solvent;
3) After the addition of sevage reagent (chloroform: the volume ratio of n-butanol is 4: 1) Deproteinizing, shaking for 30min, standing for separating protein, removing organic phase and protein between water phase and organic phase for 5-6 times; dialyzing with dialysis bag (MD 44-10000) for 12 hr, and lyophilizing to obtain Aronia melanocarpa polysaccharide.
7. The preparation method according to claim 2, characterized in that: the preparation method of the Aronia melanocarpa extract after fermentation in the step (1) comprises the following steps:
taking Aronia melanocarpa fruits and soybeans, crushing, drying until the fruits are unchanged, sterilizing, adding sterile water to be sticky, adding lactobacillus plantarum OPB15 bacteria powder, shaking uniformly, culturing in a constant-temperature incubator for 48 hours, taking out, soaking with 5-10 times of ethanol, performing ultrasonic extraction, centrifuging, filtering to obtain filtrate, cooling to room temperature, repeatedly extracting filter residues with ethanol for three times, mixing the filtrates, pouring the filtrate into a round-bottom flask, adding 5-10 times of ethanol, shaking uniformly, filtering with a 0.45um filter membrane, and taking the filtrate to obtain the Aronia melanocarpa fruit-soybean beverage;
Wherein, the Aronia melanocarpa fruit: and (3) soybean: the mass ratio of the lactobacillus plantarum OPB15 bacterial powder is 1:0.01:5.
8. the preparation method according to claim 2, characterized in that: the preparation method of the camel milk liposome in the step (1) comprises the following steps:
firstly, incubating camel milk at 35+/-1 ℃ for 10+/-1 min, continuously stirring, spin-drying water by a film dispersion method to form a honeycomb film, and performing ultrasonic treatment for 10+/-1 min under the pressure of 2500psi to prepare the camel milk liposome.
9. The preparation method according to claim 2, characterized in that: the preparation method of the active polypeptide in the step (1) comprises the following steps:
crushing hickory, wheat, peas, pollen pini and peach kernels, adding water, adjusting the pH value to be slightly alkaline pH=8.7+/-0.5, extracting protein by an alkali-dissolution acid precipitation method, freeze-drying, centrifuging at 8000rpm for 10 minutes after protease enzymolysis, and freeze-drying supernatant to obtain the active polypeptide extract.
10. The preparation method according to any one of claims 2 to 9, characterized in that: the tea tree essential oil and the clove essential oil have synergistic preservative effect and are plant source preservatives.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311389706.7A CN117414319A (en) | 2023-10-25 | 2023-10-25 | Nanometer eye cream of Aronia melanocarpa extract fermented by lactobacillus plantarum and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311389706.7A CN117414319A (en) | 2023-10-25 | 2023-10-25 | Nanometer eye cream of Aronia melanocarpa extract fermented by lactobacillus plantarum and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117414319A true CN117414319A (en) | 2024-01-19 |
Family
ID=89532024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311389706.7A Pending CN117414319A (en) | 2023-10-25 | 2023-10-25 | Nanometer eye cream of Aronia melanocarpa extract fermented by lactobacillus plantarum and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117414319A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117694549A (en) * | 2024-02-05 | 2024-03-15 | 北京衡美金叶营养健康科技有限公司 | Moisturizing, freckle-removing and whitening composition, preparation method and application |
-
2023
- 2023-10-25 CN CN202311389706.7A patent/CN117414319A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117694549A (en) * | 2024-02-05 | 2024-03-15 | 北京衡美金叶营养健康科技有限公司 | Moisturizing, freckle-removing and whitening composition, preparation method and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Synthesis, characterization and antioxidant activity of selenium modified polysaccharides from Hohenbuehelia serotina | |
CN109400734A (en) | A kind of Polysaccharides from Rosa roxburghii and the preparation method and application thereof | |
CN117414319A (en) | Nanometer eye cream of Aronia melanocarpa extract fermented by lactobacillus plantarum and preparation method thereof | |
Mukhopadhyay et al. | Isolation and characterization of extracellular polysaccharide Thelebolan produced by a newly isolated psychrophilic Antarctic fungus Thelebolus | |
CN112545962B (en) | Moisturizing and bacteriostatic gel containing aloe arborescens extract and preparation method thereof | |
KR102386296B1 (en) | Complex-fermented composition of Fabaton soybean leaves and Schisandra chinensis having enhanced anti-diabetic and anti-obesity effects and preparation method thereof | |
Su et al. | Research on degradation of polysaccharides during Hericium erinaceus fermentation | |
Geng et al. | Effects of different extraction methods on the physico-chemical characteristics and biological activities of polysaccharides from Clitocybe squamulosa | |
CN113121718B (en) | Roselle polysaccharide PSGP-2 and preparation method and application thereof | |
CN109077957B (en) | Traditional Chinese medicine composition fermentation liquor with anti-pollution effect for cosmetics and preparation and application thereof | |
CN113024681B (en) | Polygonatum sibiricum galactan and preparation method and application thereof | |
CN116875507B (en) | Wessella-J4-1 fusion and application of extracellular polysaccharide thereof in prevention and treatment of colon cancer | |
Song et al. | Effects of solution behavior on polysaccharide structure and inhibitory of α-glucosidase activity from Cordyceps militaris | |
CN115028753B (en) | Homogeneous polysaccharide of seabuckthorn with anti-tumor effect, separation and purification method and application thereof | |
CN114686542B (en) | Low molecular weight antrodia camphorate extracellular polysaccharide and preparation and application thereof | |
Mo et al. | Preparation, characterization, and bioactivities of polysaccharides fractions from sugarcane leaves | |
CN112794928B (en) | Black date polysaccharide and application thereof | |
He et al. | Components and Antioxidant Activity of the Polysaccharide from Streptomyces virginia H03 | |
CN110305816B (en) | Streptococcus thermophilus IMAU20756 and application thereof | |
CN109796538A (en) | The method for improving Porphyra yezoensis Polysaccharides bioactivity | |
CN113388046B (en) | Citron fruit polysaccharide and preparation method and application thereof | |
CN116970665B (en) | Extraction method and application of tremella aurantialba polysaccharide fermented by tremella aurantialba | |
CN115490778B (en) | Pleurotus sajor-caju polysaccharide extract and preparation method and application thereof | |
CN116574197A (en) | Tremella polysaccharide and application thereof | |
CN117567658A (en) | Paris polyphylla glucomannan and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |